Breast cancer(BC)is the most prevalent cancer in women globally.Anti-cancer advancements have enabled the killing of BC cells through various therapies;however,cancer relapse is still a major limitation and decreases ...
N.I.R.R.and K.I.M.have received a grant from the Malaysian Ministry of Higher Education.Grant number:203/PKOMP/6712025,http://portal.mygrants.gov.my/main.php.
This study offers a framework for a breast cancer computer-aided treat-ment prediction(CATP)system.The rising death rate among women due to breast cancer is a worldwide health concern that can only be addressed by ear...
Background:Breast cancer is the most commonly diagnosed malignancy among women worldwide.In contrast to Europe,it generally presents very late in Africa.As with the rest of Africa,it is the most common primary maligna...
This research was supported by 81803024(National Natural Science Foundation of China);DUT21LK23(Fundamental Research Funds for the Central Universities).
Breast cancer is a highly aggressive cancer in females. Metastasis is a major obstacle to the efficient andsuccessful treatment of breast cancer. Cetyltrimethylammonium bromide (CTAB) has anti-tumor effects on a varie...
This research was supported by the University of Electronic Science and Technology of China;China Postdoctoral Science Foundation(No.2018M633347).
We have developed a computer-aided diagnosis system based on a convolutional neural network that aims to classify breast mass lesions in optical tomographic images obtained using a diffuse optical tomography system,wh...
National Natural Science Foundation of China(Grant No.81130059);the National Research Fund for Fundamental Key Project(Grant No.2009CB930300)
Tumor metastasis emerges as a crucial target for tumor therapy. In this study, a tumor metastasis targeting peptide(TMT) was conjugated to a lipid material(PEG-DSPE) to obtain the targeting compound(TMT-PEG-DSPE...
Project supported in part by grants to Xiaodong ZHANG from the National Basic Research Program of China (973 Program, No 2007CB914800), National Natural Science Foundation of China (No 30570698), and Tianjin Natural Scientific Foundation (No 033801211).Acknowledgements We thank Dr Chuan-shu HUANG (from Nelson Institute of Environmental Medicine, New York University School of Medicine, New York, USA) for providing the pGL-NF-κB and pRL-TK reporter plasmid.
Aim: It has been reported that stem cells are able to home to tumorigenesis and inhibit the proliferation of tumor cells. The purpose of our study was to demonstrate the molecular mechanism of the inhibitory prolifer...